Solstice Advanced Materials, the chemical company spun out Honeywell, has announced plans to invest more than $220-mn in multiple projects to expand production at its existing ballistic fibre manufacturing facility in Colonial Heights (Chesterfield County, Virginia, US).
The Colonial Heights facility has been a cornerstone of US defence supply chains for over two decades, producing Spectra fibre and composite materials used in helmets, vests, vehicle armour and naval applications, along with an array of industrial applications.
Through its investment, Solstice will enhance its facility with new fibre spinning, composite coating and analytical capabilities, creating one of the most sophisticated ballistic materials production hubs in North America. Construction and equipment installation are expected to occur between 2025 and 2029, with operational benefits expected to ramp through the projected completion date of Sept. 30, 2030.
“This investment underscores Solstice’s commitment to maintaining technology leadership in high-performance protective materials, strengthening US-based manufacturing and enhancing supply chain resiliency for defence-critical materials,” said Mr. David Sewell, President and CEO of Solstice Advanced Materials.
The expansion will increase capacity for Spectra and Spectra Shield technologies, featuring ultra-high molecular weight polyethylene (UHMWPE) fibres that are up to 15 times stronger than steel and 65% lighter than aramid fabrics. The Colonial Heights facility’s R&D and prototyping capabilities – spanning fibre spinning, ballistic testing and composite fabrication – enable Solstice to accelerate innovation cycles and deliver advancements such as next-generation lightweight armour systems and advanced soldier protection solutions.
Boosting stannous fluoride capacity in Germany
In another development, Solstice has strengthened its position in the global oral care supply chain with the recent completion of a €5.5-mn expansion of its stannous fluoride (SnF₂) manufacturing facility in Seelze, Germany.
The expansion increases Solstice’s production capacity by approximately 45%. The recent investment comes as stannous fluoride continues to gain momentum as a key ingredient in modern toothpaste formulations.
“This expansion was driven by what our customers need most: confidence that they can scale without compromise. The expansion will allow Solstice to support our customers’ innovation and long-term growth, today and into the future,” said Mr. Gerald Talholff, Seelze site leader and local Managing Director at Solstice.
Demand for stannous fluoride has surged in recent years, with global demand projected to grow at approximately 5-6% annually through the next decade. This growth is driven by large-scale toothpaste portfolio reformulations and increasing consumer preference for multi-benefit oral care products. Offering a powerful combination of cavity protection, enamel strengthening, gum health support and sensitivity reduction, stannous fluoride has become a critical ingredient in next-generation oral care brands.
“This investment reflects Solstice’s broader strategy as an independent speciality materials company to make disciplined, targeted investments in high-value markets where materials science supports improved health outcomes,” said Mr. Michael Sweeney, Global Product & Marketing Leader at Solstice. “By expanding our stannous fluoride production, we are directly addressing a critical customer need, enabling our partners to scale production, reformulate portfolios, plan for long-term growth and innovate across next-generation oral care.”


20 January, 2026 16:55:16 IST 

















